JS015

· Shanghai Junshi Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JS015, covering 2024-12-20 to 2025-06-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer [Phase 2]

See pricing